

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.72490334 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.72490334 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.67468197 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.67468197 |
| 5 | lysine metabolic process (GO:0006553) | 5.44019132 |
| 6 | lysine catabolic process (GO:0006554) | 5.44019132 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.32160011 |
| 8 | exogenous drug catabolic process (GO:0042738) | 5.28772930 |
| 9 | fatty acid beta-oxidation (GO:0006635) | 5.24413265 |
| 10 | fatty acid transmembrane transport (GO:1902001) | 5.16452480 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 5.11143981 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.11082859 |
| 13 | carnitine shuttle (GO:0006853) | 5.10459595 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 4.98725758 |
| 15 | drug catabolic process (GO:0042737) | 4.94624638 |
| 16 | kynurenine metabolic process (GO:0070189) | 4.94052780 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90170516 |
| 18 | 2-oxoglutarate metabolic process (GO:0006103) | 4.77720467 |
| 19 | fatty acid oxidation (GO:0019395) | 4.74549105 |
| 20 | amino-acid betaine metabolic process (GO:0006577) | 4.73994966 |
| 21 | fatty acid catabolic process (GO:0009062) | 4.72865007 |
| 22 | cellular ketone body metabolic process (GO:0046950) | 4.66912949 |
| 23 | lipid oxidation (GO:0034440) | 4.66653370 |
| 24 | acetyl-CoA metabolic process (GO:0006084) | 4.61221675 |
| 25 | tryptophan catabolic process (GO:0006569) | 4.61111810 |
| 26 | indole-containing compound catabolic process (GO:0042436) | 4.61111810 |
| 27 | indolalkylamine catabolic process (GO:0046218) | 4.61111810 |
| 28 | tricarboxylic acid cycle (GO:0006099) | 4.60217115 |
| 29 | bile acid biosynthetic process (GO:0006699) | 4.60163094 |
| 30 | * regulation of sequestering of triglyceride (GO:0010889) | 4.49764561 |
| 31 | short-chain fatty acid metabolic process (GO:0046459) | 4.43482123 |
| 32 | aspartate family amino acid catabolic process (GO:0009068) | 4.39943699 |
| 33 | * regulation of triglyceride catabolic process (GO:0010896) | 4.38763454 |
| 34 | urea cycle (GO:0000050) | 4.38585216 |
| 35 | urea metabolic process (GO:0019627) | 4.38585216 |
| 36 | monocarboxylic acid catabolic process (GO:0072329) | 4.37213706 |
| 37 | tryptophan metabolic process (GO:0006568) | 4.34904434 |
| 38 | sulfur amino acid catabolic process (GO:0000098) | 4.27300948 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 4.24413372 |
| 40 | carnitine metabolic process (GO:0009437) | 4.23882386 |
| 41 | behavioral response to nicotine (GO:0035095) | 4.22810979 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.19637803 |
| 43 | branched-chain amino acid catabolic process (GO:0009083) | 4.18337653 |
| 44 | cysteine metabolic process (GO:0006534) | 4.12594163 |
| 45 | negative regulation of fibrinolysis (GO:0051918) | 4.12516164 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.10618536 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.10618536 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 4.09430240 |
| 49 | complement activation, alternative pathway (GO:0006957) | 4.08901350 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.05873618 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.03672024 |
| 52 | ketone body metabolic process (GO:1902224) | 4.01896171 |
| 53 | biotin metabolic process (GO:0006768) | 4.01652488 |
| 54 | regulation of protein activation cascade (GO:2000257) | 4.00077416 |
| 55 | protein carboxylation (GO:0018214) | 3.99687349 |
| 56 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.99687349 |
| 57 | * regulation of fatty acid oxidation (GO:0046320) | 3.97261496 |
| 58 | regulation of fibrinolysis (GO:0051917) | 3.96843550 |
| 59 | carnitine transmembrane transport (GO:1902603) | 3.96614903 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 3.92644607 |
| 61 | valine metabolic process (GO:0006573) | 3.92126441 |
| 62 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.90425878 |
| 63 | bile acid metabolic process (GO:0008206) | 3.87566918 |
| 64 | coenzyme catabolic process (GO:0009109) | 3.86263471 |
| 65 | organic acid catabolic process (GO:0016054) | 3.85339527 |
| 66 | carboxylic acid catabolic process (GO:0046395) | 3.85339527 |
| 67 | regulation of cholesterol esterification (GO:0010872) | 3.84057635 |
| 68 | ethanol oxidation (GO:0006069) | 3.83766537 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 3.81188728 |
| 70 | phospholipid homeostasis (GO:0055091) | 3.80811080 |
| 71 | macromolecular complex remodeling (GO:0034367) | 3.80457619 |
| 72 | plasma lipoprotein particle remodeling (GO:0034369) | 3.80457619 |
| 73 | protein-lipid complex remodeling (GO:0034368) | 3.80457619 |
| 74 | branched-chain amino acid metabolic process (GO:0009081) | 3.78002957 |
| 75 | carnitine transport (GO:0015879) | 3.76216364 |
| 76 | amino-acid betaine transport (GO:0015838) | 3.76216364 |
| 77 | aromatic amino acid family metabolic process (GO:0009072) | 3.75299000 |
| 78 | NADH metabolic process (GO:0006734) | 3.75016981 |
| 79 | regulation of complement activation (GO:0030449) | 3.72798524 |
| 80 | reverse cholesterol transport (GO:0043691) | 3.72552536 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.67236698 |
| 82 | omega-hydroxylase P450 pathway (GO:0097267) | 3.66350253 |
| 83 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.65327812 |
| 84 | * positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.64032702 |
| 85 | * positive regulation of fatty acid oxidation (GO:0046321) | 3.63710394 |
| 86 | tyrosine metabolic process (GO:0006570) | 3.61373191 |
| 87 | oxidative demethylation (GO:0070989) | 3.57510317 |
| 88 | S-adenosylmethionine metabolic process (GO:0046500) | 3.56522560 |
| 89 | indolalkylamine metabolic process (GO:0006586) | 3.56362126 |
| 90 | phospholipid efflux (GO:0033700) | 3.56308376 |
| 91 | * positive regulation of lipid catabolic process (GO:0050996) | 3.55999794 |
| 92 | succinate metabolic process (GO:0006105) | 3.54881506 |
| 93 | regulation of cholesterol metabolic process (GO:0090181) | 3.52175575 |
| 94 | tricarboxylic acid metabolic process (GO:0072350) | 3.46482661 |
| 95 | glutamate metabolic process (GO:0006536) | 3.42164020 |
| 96 | oxaloacetate metabolic process (GO:0006107) | 3.41169694 |
| 97 | cellular modified amino acid catabolic process (GO:0042219) | 3.31338307 |
| 98 | L-fucose catabolic process (GO:0042355) | 3.31026400 |
| 99 | fucose catabolic process (GO:0019317) | 3.31026400 |
| 100 | L-fucose metabolic process (GO:0042354) | 3.31026400 |
| 101 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.28853799 |
| 102 | glycine metabolic process (GO:0006544) | 3.27476409 |
| 103 | thioester metabolic process (GO:0035383) | 3.27441755 |
| 104 | acyl-CoA metabolic process (GO:0006637) | 3.27441755 |
| 105 | negative regulation of sterol transport (GO:0032372) | 3.27304499 |
| 106 | negative regulation of cholesterol transport (GO:0032375) | 3.27304499 |
| 107 | benzene-containing compound metabolic process (GO:0042537) | 3.24792530 |
| 108 | amine catabolic process (GO:0009310) | 3.23544315 |
| 109 | cellular biogenic amine catabolic process (GO:0042402) | 3.23544315 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.23143272 |
| 111 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.23143272 |
| 112 | epoxygenase P450 pathway (GO:0019373) | 3.22340316 |
| 113 | regulation of hexokinase activity (GO:1903299) | 3.20557954 |
| 114 | regulation of glucokinase activity (GO:0033131) | 3.20557954 |
| 115 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.20181852 |
| 116 | regulation of skeletal muscle contraction (GO:0014819) | 3.17569819 |
| 117 | actin-myosin filament sliding (GO:0033275) | 3.14839070 |
| 118 | muscle filament sliding (GO:0030049) | 3.14839070 |
| 119 | amino acid salvage (GO:0043102) | 3.04009098 |
| 120 | L-methionine salvage (GO:0071267) | 3.04009098 |
| 121 | L-methionine biosynthetic process (GO:0071265) | 3.04009098 |
| 122 | synaptic transmission, cholinergic (GO:0007271) | 3.01760059 |
| 123 | regulation of memory T cell differentiation (GO:0043380) | 2.96979195 |
| 124 | ubiquinone biosynthetic process (GO:0006744) | 2.96687791 |
| 125 | drug metabolic process (GO:0017144) | 2.93341355 |
| 126 | arginine metabolic process (GO:0006525) | 2.91920970 |
| 127 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.91565224 |
| 128 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.89124378 |
| 129 | detection of light stimulus involved in visual perception (GO:0050908) | 2.89124378 |
| 130 | regulation of action potential (GO:0098900) | 2.86114609 |
| 131 | quinone biosynthetic process (GO:1901663) | 2.82843346 |
| 132 | NAD biosynthetic process (GO:0009435) | 2.82768155 |
| 133 | ethanol metabolic process (GO:0006067) | 2.80956892 |
| 134 | alkaloid metabolic process (GO:0009820) | 2.78746032 |
| 135 | arginine catabolic process (GO:0006527) | 2.72825372 |
| 136 | flavonoid metabolic process (GO:0009812) | 2.71797269 |
| 137 | dopamine transport (GO:0015872) | 2.69487632 |
| 138 | indole-containing compound metabolic process (GO:0042430) | 2.66080007 |
| 139 | alanine transport (GO:0032328) | 2.65432010 |
| 140 | creatine metabolic process (GO:0006600) | 2.61950661 |
| 141 | ubiquinone metabolic process (GO:0006743) | 2.60812098 |
| 142 | imidazole-containing compound metabolic process (GO:0052803) | 2.57995858 |
| 143 | epithelial cilium movement (GO:0003351) | 2.57034871 |
| 144 | DNA deamination (GO:0045006) | 2.56783393 |
| 145 | auditory receptor cell stereocilium organization (GO:0060088) | 2.55630221 |
| 146 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.54134860 |
| 147 | regulation of relaxation of muscle (GO:1901077) | 2.52726334 |
| 148 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.52512525 |
| 149 | actin-mediated cell contraction (GO:0070252) | 2.51775956 |
| 150 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.51436056 |
| 151 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.49754939 |
| 152 | axoneme assembly (GO:0035082) | 2.47433939 |
| 153 | methionine biosynthetic process (GO:0009086) | 2.46039567 |
| 154 | brown fat cell differentiation (GO:0050873) | 2.43656052 |
| 155 | piRNA metabolic process (GO:0034587) | 2.43492330 |
| 156 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.43240439 |
| 157 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.42204256 |
| 158 | xenobiotic catabolic process (GO:0042178) | 2.41101020 |
| 159 | myofibril assembly (GO:0030239) | 2.40670336 |
| 160 | glycerol metabolic process (GO:0006071) | 2.39983519 |
| 161 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.38885114 |
| 162 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.38885114 |
| 163 | skeletal muscle contraction (GO:0003009) | 2.38336395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.33705305 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.11953640 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.27382608 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.67177782 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.11879686 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.80028603 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.10153493 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.97440575 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93850808 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.23652380 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.09311276 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 3.00191227 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80375769 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.76381043 |
| 15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.46842972 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.42414122 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.33950404 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.23491798 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.20280023 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06908383 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3330083 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.95320932 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93669060 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.89224041 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88228001 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81034682 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80755254 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72718062 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.71607391 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68998847 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68698286 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63865964 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62319590 |
| 34 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.59022421 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55711963 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52171449 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47498591 |
| 38 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.47162292 |
| 39 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.47162292 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45783619 |
| 41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.45457248 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40184627 |
| 43 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.39754030 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39599882 |
| 45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.36816948 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.36538385 |
| 47 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.36535991 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35934334 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.34698819 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33186644 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32771707 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32327416 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32327416 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30685901 |
| 55 | TCF4_23295773_ChIP-Seq_U87_Human | 1.29206343 |
| 56 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.29175098 |
| 57 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.28985736 |
| 58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.28985736 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28882055 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28833437 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28198335 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27863682 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26952178 |
| 64 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26685079 |
| 65 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26685079 |
| 66 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26522201 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25642185 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25394314 |
| 69 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.24909370 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24705051 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22622292 |
| 72 | NCOR_22424771_ChIP-Seq_293T_Human | 1.22383102 |
| 73 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21677045 |
| 74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21456656 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21348831 |
| 76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21045257 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21045257 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21002746 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20049217 |
| 80 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19705915 |
| 81 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19272363 |
| 82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.19043859 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19024323 |
| 84 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15444895 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15147385 |
| 86 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.14286897 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13554954 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.12998804 |
| 89 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12886101 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10855785 |
| 91 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10814383 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10461283 |
| 93 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.09564344 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08954871 |
| 95 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08437539 |
| 96 | ERA_21632823_ChIP-Seq_H3396_Human | 1.08314267 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07413939 |
| 98 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05245325 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.04854679 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04493573 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04013014 |
| 102 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03869119 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02806795 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02745259 |
| 105 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01776767 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01653570 |
| 107 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01194992 |
| 108 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00412282 |
| 109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00145657 |
| 110 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99046276 |
| 111 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.97849091 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95741811 |
| 113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90901710 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85944488 |
| 115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83366390 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82279104 |
| 117 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.82217350 |
| 118 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80278333 |
| 119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79055921 |
| 120 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.73473360 |
| 121 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.70988858 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69773053 |
| 123 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69559169 |
| 124 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.69504167 |
| 125 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68791606 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67995111 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67995111 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.66162790 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.64178725 |
| 130 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64159843 |
| 131 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63908026 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.63749912 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63668453 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63388605 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.62749879 |
| 136 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.62522959 |
| 137 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62187500 |
| 138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.61069731 |
| 139 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60073985 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58270913 |
| 141 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.57382918 |
| 142 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.56870563 |
| 143 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.56684584 |
| 144 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.56344845 |
| 145 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.55009735 |
| 146 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54677661 |
| 147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.54545443 |
| 148 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.54380994 |
| 149 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52552429 |
| 150 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52507715 |
| 151 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.51718347 |
| 152 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.50517757 |
| 153 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.50492035 |
| 154 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.50403407 |
| 155 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50387358 |
| 156 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.50187728 |
| 157 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.49899901 |
| 158 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.49307567 |
| 159 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.48309908 |
| 160 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47677546 |
| 161 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.47446379 |
| 162 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46857404 |
| 163 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46709370 |
| 164 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.46241593 |
| 165 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.45018002 |
| 166 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44298826 |
| 167 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.43807156 |
| 168 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43606896 |
| 169 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43365048 |
| 170 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.42753727 |
| 171 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42548939 |
| 172 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.41877962 |
| 173 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.41084819 |
| 174 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40935937 |
| 175 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.40704509 |
| 176 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.40461353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.97602610 |
| 2 | MP0005360_urolithiasis | 5.29753895 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.00003666 |
| 4 | MP0005365_abnormal_bile_salt | 4.80030946 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 4.14867396 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.62664260 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.46283860 |
| 8 | MP0003646_muscle_fatigue | 3.27531192 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.10255355 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.10001274 |
| 11 | MP0003252_abnormal_bile_duct | 2.99159624 |
| 12 | MP0005670_abnormal_white_adipose | 2.92061519 |
| 13 | MP0009840_abnormal_foam_cell | 2.78474773 |
| 14 | MP0004130_abnormal_muscle_cell | 2.67747709 |
| 15 | MP0005332_abnormal_amino_acid | 2.53766024 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.35229504 |
| 17 | MP0003195_calcinosis | 2.31975821 |
| 18 | MP0005330_cardiomyopathy | 2.28770249 |
| 19 | MP0005083_abnormal_biliary_tract | 2.19746539 |
| 20 | MP0000751_myopathy | 2.14490475 |
| 21 | MP0004215_abnormal_myocardial_fiber | 2.14427199 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.11353967 |
| 23 | MP0005666_abnormal_adipose_tissue | 2.10090457 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.08445650 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 2.02996175 |
| 26 | MP0008872_abnormal_physiological_respon | 1.94282230 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.93314415 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.90933668 |
| 29 | MP0000609_abnormal_liver_physiology | 1.88375237 |
| 30 | MP0005551_abnormal_eye_electrophysiolog | 1.84099453 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.79868399 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.77355384 |
| 33 | MP0000749_muscle_degeneration | 1.68320176 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.67965074 |
| 35 | MP0002971_abnormal_brown_adipose | 1.65907846 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.56267595 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53568797 |
| 38 | MP0004087_abnormal_muscle_fiber | 1.52950115 |
| 39 | MP0005451_abnormal_body_composition | 1.49042446 |
| 40 | MP0008775_abnormal_heart_ventricle | 1.48565513 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.47785809 |
| 42 | MP0002972_abnormal_cardiac_muscle | 1.45868501 |
| 43 | MP0005385_cardiovascular_system_phenoty | 1.45275494 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 1.45275494 |
| 45 | MP0006138_congestive_heart_failure | 1.41780816 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.37805750 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 1.37166481 |
| 48 | MP0002269_muscular_atrophy | 1.35242402 |
| 49 | MP0003136_yellow_coat_color | 1.32438479 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.32105185 |
| 51 | MP0010630_abnormal_cardiac_muscle | 1.30314096 |
| 52 | MP0002102_abnormal_ear_morphology | 1.28622373 |
| 53 | MP0009745_abnormal_behavioral_response | 1.28011042 |
| 54 | MP0005620_abnormal_muscle_contractility | 1.27161836 |
| 55 | MP0003137_abnormal_impulse_conducting | 1.27083300 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.25411382 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.25298691 |
| 58 | MP0005535_abnormal_body_temperature | 1.24724681 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.23685285 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.23614697 |
| 61 | MP0001764_abnormal_homeostasis | 1.23375902 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.22264243 |
| 63 | MP0005375_adipose_tissue_phenotype | 1.21525513 |
| 64 | MP0006276_abnormal_autonomic_nervous | 1.20356580 |
| 65 | MP0002736_abnormal_nociception_after | 1.19451185 |
| 66 | MP0004142_abnormal_muscle_tone | 1.19015437 |
| 67 | MP0005253_abnormal_eye_physiology | 1.18266208 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 1.17293325 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.16630212 |
| 70 | MP0003186_abnormal_redox_activity | 1.14609878 |
| 71 | MP0009697_abnormal_copulation | 1.12768288 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 1.11522876 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.11055735 |
| 74 | MP0004885_abnormal_endolymph | 1.10848356 |
| 75 | MP0003868_abnormal_feces_composition | 1.10517344 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 1.10129912 |
| 77 | MP0006292_abnormal_olfactory_placode | 1.09566198 |
| 78 | MP0004147_increased_porphyrin_level | 1.08119688 |
| 79 | MP0004133_heterotaxia | 1.07433713 |
| 80 | MP0005334_abnormal_fat_pad | 1.07361367 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 1.06284872 |
| 82 | MP0008877_abnormal_DNA_methylation | 1.05169801 |
| 83 | MP0005266_abnormal_metabolism | 1.05104907 |
| 84 | MP0000750_abnormal_muscle_regeneration | 1.04386623 |
| 85 | MP0002332_abnormal_exercise_endurance | 1.02892906 |
| 86 | MP0004484_altered_response_of | 1.02423010 |
| 87 | MP0002272_abnormal_nervous_system | 1.01058727 |
| 88 | MP0001485_abnormal_pinna_reflex | 0.99771872 |
| 89 | MP0002106_abnormal_muscle_physiology | 0.96291335 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.95533477 |
| 91 | MP0009046_muscle_twitch | 0.95331565 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.93738831 |
| 93 | MP0000427_abnormal_hair_cycle | 0.93009582 |
| 94 | MP0004085_abnormal_heartbeat | 0.92752390 |
| 95 | MP0000569_abnormal_digit_pigmentation | 0.92124739 |
| 96 | MP0004924_abnormal_behavior | 0.91625851 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.91625851 |
| 98 | MP0001486_abnormal_startle_reflex | 0.90802977 |
| 99 | MP0000598_abnormal_liver_morphology | 0.89938076 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.89914839 |
| 101 | MP0002735_abnormal_chemical_nociception | 0.89760445 |
| 102 | MP0003878_abnormal_ear_physiology | 0.89281867 |
| 103 | MP0005377_hearing/vestibular/ear_phenot | 0.89281867 |
| 104 | MP0000747_muscle_weakness | 0.89115152 |
| 105 | MP0003011_delayed_dark_adaptation | 0.87712444 |
| 106 | MP0009763_increased_sensitivity_to | 0.85727876 |
| 107 | MP0009115_abnormal_fat_cell | 0.84729360 |
| 108 | MP0006072_abnormal_retinal_apoptosis | 0.84178501 |
| 109 | MP0000759_abnormal_skeletal_muscle | 0.82563504 |
| 110 | MP0003724_increased_susceptibility_to | 0.82517443 |
| 111 | MP0005647_abnormal_sex_gland | 0.82149298 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.79114226 |
| 113 | MP0002928_abnormal_bile_duct | 0.78958301 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.78539224 |
| 115 | MP0005369_muscle_phenotype | 0.77232427 |
| 116 | MP0001661_extended_life_span | 0.76787350 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.75814395 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 0.74948622 |
| 119 | MP0005448_abnormal_energy_balance | 0.74421859 |
| 120 | MP0003828_pulmonary_edema | 0.73341276 |
| 121 | MP0002970_abnormal_white_adipose | 0.72880990 |
| 122 | MP0001502_abnormal_circadian_rhythm | 0.72710050 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.71961592 |
| 124 | MP0002064_seizures | 0.71442800 |
| 125 | MP0000343_altered_response_to | 0.70503582 |
| 126 | MP0002108_abnormal_muscle_morphology | 0.69519211 |
| 127 | MP0009780_abnormal_chondrocyte_physiolo | 0.68874545 |
| 128 | MP0002127_abnormal_cardiovascular_syste | 0.68558243 |
| 129 | MP0001970_abnormal_pain_threshold | 0.68159269 |
| 130 | MP0009764_decreased_sensitivity_to | 0.65315828 |
| 131 | MP0000604_amyloidosis | 0.64765890 |
| 132 | MP0005165_increased_susceptibility_to | 0.63651040 |
| 133 | MP0003690_abnormal_glial_cell | 0.62897590 |
| 134 | MP0008469_abnormal_protein_level | 0.60666970 |
| 135 | MP0004510_myositis | 0.57714104 |
| 136 | MP0005636_abnormal_mineral_homeostasis | 0.57001561 |
| 137 | MP0002822_catalepsy | 0.55631704 |
| 138 | MP0001853_heart_inflammation | 0.53064553 |
| 139 | MP0001756_abnormal_urination | 0.52627365 |
| 140 | MP0000003_abnormal_adipose_tissue | 0.52224211 |
| 141 | MP0004043_abnormal_pH_regulation | 0.52180363 |
| 142 | MP0003953_abnormal_hormone_level | 0.50434057 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.49783185 |
| 144 | MP0002254_reproductive_system_inflammat | 0.49064909 |
| 145 | MP0003950_abnormal_plasma_membrane | 0.48322971 |
| 146 | MP0002128_abnormal_blood_circulation | 0.46415821 |
| 147 | MP0004233_abnormal_muscle_weight | 0.44703341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.13660079 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.83881090 |
| 3 | Xanthomatosis (HP:0000991) | 4.81968373 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.80377386 |
| 5 | Hyperammonemia (HP:0001987) | 4.76610106 |
| 6 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.73943586 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.71535295 |
| 8 | Hyperglycinuria (HP:0003108) | 4.70300091 |
| 9 | Ketosis (HP:0001946) | 4.59292598 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.43991756 |
| 11 | Myoglobinuria (HP:0002913) | 4.33340595 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.25210250 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.24578469 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.24578469 |
| 15 | Ketoacidosis (HP:0001993) | 4.13306577 |
| 16 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.12688781 |
| 17 | Dicarboxylic aciduria (HP:0003215) | 4.12688781 |
| 18 | Prolonged partial thromboplastin time (HP:0003645) | 4.08297486 |
| 19 | Muscle fiber inclusion bodies (HP:0100299) | 4.07887030 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 4.04146998 |
| 21 | Nemaline bodies (HP:0003798) | 4.00201863 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 3.98576594 |
| 23 | Hyperglycinemia (HP:0002154) | 3.94168650 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.92638883 |
| 25 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.91821531 |
| 26 | Hypolipoproteinemia (HP:0010981) | 3.76275282 |
| 27 | Sudden death (HP:0001699) | 3.65697454 |
| 28 | Pancreatic cysts (HP:0001737) | 3.65631762 |
| 29 | Cerebral edema (HP:0002181) | 3.61796895 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.60010408 |
| 31 | Epidermoid cyst (HP:0200040) | 3.56337919 |
| 32 | Complement deficiency (HP:0004431) | 3.54871093 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.53364060 |
| 34 | Exercise-induced myalgia (HP:0003738) | 3.47517096 |
| 35 | Ventricular tachycardia (HP:0004756) | 3.27875811 |
| 36 | Hepatic necrosis (HP:0002605) | 3.27548128 |
| 37 | Pancreatic fibrosis (HP:0100732) | 3.27326935 |
| 38 | True hermaphroditism (HP:0010459) | 3.23099189 |
| 39 | Molar tooth sign on MRI (HP:0002419) | 3.22317976 |
| 40 | Abnormality of midbrain morphology (HP:0002418) | 3.22317976 |
| 41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.18751940 |
| 42 | Congenital stationary night blindness (HP:0007642) | 3.18683108 |
| 43 | Generalized aminoaciduria (HP:0002909) | 3.13866459 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.11647423 |
| 45 | Hyperventilation (HP:0002883) | 3.10573247 |
| 46 | Lethargy (HP:0001254) | 3.10207376 |
| 47 | Abnormality of the renal cortex (HP:0011035) | 3.05016533 |
| 48 | Type II lissencephaly (HP:0007260) | 3.04926020 |
| 49 | Metabolic acidosis (HP:0001942) | 3.04877611 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 3.04521099 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 3.03943564 |
| 52 | Nephronophthisis (HP:0000090) | 2.98804211 |
| 53 | Joint hemorrhage (HP:0005261) | 2.96830836 |
| 54 | Palpitations (HP:0001962) | 2.92548300 |
| 55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.85317451 |
| 56 | Abnormality of the common coagulation pathway (HP:0010990) | 2.83421454 |
| 57 | Acute encephalopathy (HP:0006846) | 2.79758637 |
| 58 | Exercise-induced muscle cramps (HP:0003710) | 2.77657634 |
| 59 | Calf muscle hypertrophy (HP:0008981) | 2.77104484 |
| 60 | Right ventricular cardiomyopathy (HP:0011663) | 2.76659480 |
| 61 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.76263180 |
| 62 | Abnormality of alanine metabolism (HP:0010916) | 2.76263180 |
| 63 | Hyperalaninemia (HP:0003348) | 2.76263180 |
| 64 | Skin nodule (HP:0200036) | 2.74517977 |
| 65 | Increased muscle lipid content (HP:0009058) | 2.74272676 |
| 66 | Type 1 muscle fiber predominance (HP:0003803) | 2.70227429 |
| 67 | Renal cortical cysts (HP:0000803) | 2.69017388 |
| 68 | Lipoatrophy (HP:0100578) | 2.64144891 |
| 69 | Nausea (HP:0002018) | 2.64005430 |
| 70 | Atrioventricular block (HP:0001678) | 2.63282658 |
| 71 | Hypercholesterolemia (HP:0003124) | 2.62586338 |
| 72 | Abnormality of the renal medulla (HP:0100957) | 2.61152029 |
| 73 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.58701526 |
| 74 | Pendular nystagmus (HP:0012043) | 2.54395925 |
| 75 | Vomiting (HP:0002013) | 2.53584102 |
| 76 | Bile duct proliferation (HP:0001408) | 2.51289532 |
| 77 | Abnormal biliary tract physiology (HP:0012439) | 2.51289532 |
| 78 | Hyporeflexia of lower limbs (HP:0002600) | 2.50253059 |
| 79 | Attenuation of retinal blood vessels (HP:0007843) | 2.49311041 |
| 80 | Atrial fibrillation (HP:0005110) | 2.48561056 |
| 81 | Dilated cardiomyopathy (HP:0001644) | 2.47408362 |
| 82 | Abnormality of the intrinsic pathway (HP:0010989) | 2.47040398 |
| 83 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.46902640 |
| 84 | Abnormality of complement system (HP:0005339) | 2.45739149 |
| 85 | Hypoglycemic seizures (HP:0002173) | 2.42049407 |
| 86 | Tubular atrophy (HP:0000092) | 2.41418303 |
| 87 | Fat malabsorption (HP:0002630) | 2.40726812 |
| 88 | Muscle fiber splitting (HP:0003555) | 2.38680642 |
| 89 | Proximal tubulopathy (HP:0000114) | 2.38620943 |
| 90 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.38320695 |
| 91 | Hyperbilirubinemia (HP:0002904) | 2.37894433 |
| 92 | Cystic liver disease (HP:0006706) | 2.36803395 |
| 93 | Delayed CNS myelination (HP:0002188) | 2.35961570 |
| 94 | Abolished electroretinogram (ERG) (HP:0000550) | 2.35714753 |
| 95 | Cholelithiasis (HP:0001081) | 2.35285964 |
| 96 | Abnormal drinking behavior (HP:0030082) | 2.34870330 |
| 97 | Polydipsia (HP:0001959) | 2.34870330 |
| 98 | Heart block (HP:0012722) | 2.34489000 |
| 99 | Decreased central vision (HP:0007663) | 2.33224712 |
| 100 | Large for gestational age (HP:0001520) | 2.31263747 |
| 101 | Lactic acidosis (HP:0003128) | 2.31008147 |
| 102 | Hepatocellular necrosis (HP:0001404) | 2.29525376 |
| 103 | Primary atrial arrhythmia (HP:0001692) | 2.26405126 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.26213976 |
| 105 | Asymmetric septal hypertrophy (HP:0001670) | 2.25655125 |
| 106 | Acute necrotizing encephalopathy (HP:0006965) | 2.25144676 |
| 107 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.22993625 |
| 108 | Hyperglycemia (HP:0003074) | 2.21726294 |
| 109 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.21710168 |
| 110 | Genetic anticipation (HP:0003743) | 2.20962494 |
| 111 | Absent/shortened dynein arms (HP:0200106) | 2.19661008 |
| 112 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19661008 |
| 113 | Chronic hepatic failure (HP:0100626) | 2.18214069 |
| 114 | Abnormality of purine metabolism (HP:0004352) | 2.18089076 |
| 115 | Abnormal atrioventricular conduction (HP:0005150) | 2.17885306 |
| 116 | Fair hair (HP:0002286) | 2.17405310 |
| 117 | Bundle branch block (HP:0011710) | 2.17033793 |
| 118 | Abnormality of nucleobase metabolism (HP:0010932) | 2.16841998 |
| 119 | Supraventricular tachycardia (HP:0004755) | 2.16713450 |
| 120 | Syncope (HP:0001279) | 2.15989461 |
| 121 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.14347844 |
| 122 | Gaze-evoked nystagmus (HP:0000640) | 2.12994210 |
| 123 | Supraventricular arrhythmia (HP:0005115) | 2.12082840 |
| 124 | Abnormality of the calf musculature (HP:0001430) | 2.11993752 |
| 125 | Cerebellar dysplasia (HP:0007033) | 2.11394922 |
| 126 | Ragged-red muscle fibers (HP:0003200) | 2.10408711 |
| 127 | EMG: myopathic abnormalities (HP:0003458) | 2.08875667 |
| 128 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.08411169 |
| 129 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.08411169 |
| 130 | Progressive cerebellar ataxia (HP:0002073) | 2.08296635 |
| 131 | Rimmed vacuoles (HP:0003805) | 2.08291507 |
| 132 | Gout (HP:0001997) | 2.07999436 |
| 133 | Increased connective tissue (HP:0009025) | 2.06143111 |
| 134 | Myocardial infarction (HP:0001658) | 2.05423651 |
| 135 | Medial flaring of the eyebrow (HP:0010747) | 2.05061175 |
| 136 | Abnormality of glycolysis (HP:0004366) | 2.04552256 |
| 137 | Increased serum pyruvate (HP:0003542) | 2.04552256 |
| 138 | Hypochromic microcytic anemia (HP:0004840) | 2.04001466 |
| 139 | Late onset (HP:0003584) | 2.03611406 |
| 140 | Abnormality of proline metabolism (HP:0010907) | 2.03229946 |
| 141 | Hydroxyprolinuria (HP:0003080) | 2.03229946 |
| 142 | Inability to walk (HP:0002540) | 2.02849084 |
| 143 | Conjunctival hamartoma (HP:0100780) | 2.01419149 |
| 144 | Congenital hepatic fibrosis (HP:0002612) | 1.99441896 |
| 145 | Distal arthrogryposis (HP:0005684) | 1.98980184 |
| 146 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98716187 |
| 147 | Hepatocellular carcinoma (HP:0001402) | 1.97127290 |
| 148 | Severe muscular hypotonia (HP:0006829) | 1.95185496 |
| 149 | Broad-based gait (HP:0002136) | 1.95053022 |
| 150 | Increased corneal curvature (HP:0100692) | 1.95017059 |
| 151 | Keratoconus (HP:0000563) | 1.95017059 |
| 152 | Methylmalonic aciduria (HP:0012120) | 1.93620728 |
| 153 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.90392736 |
| 154 | Areflexia of lower limbs (HP:0002522) | 1.89587848 |
| 155 | Stomatitis (HP:0010280) | 1.89354141 |
| 156 | Mitochondrial inheritance (HP:0001427) | 1.88996964 |
| 157 | Polyuria (HP:0000103) | 1.88381101 |
| 158 | Furrowed tongue (HP:0000221) | 1.81594772 |
| 159 | Decreased circulating renin level (HP:0003351) | 1.78047800 |
| 160 | Progressive macrocephaly (HP:0004481) | 1.77161857 |
| 161 | Cerebral palsy (HP:0100021) | 1.76064589 |
| 162 | Male pseudohermaphroditism (HP:0000037) | 1.75828043 |
| 163 | Left ventricular hypertrophy (HP:0001712) | 1.73057053 |
| 164 | Optic disc pallor (HP:0000543) | 1.72760513 |
| 165 | Absent phalangeal crease (HP:0006109) | 1.72489090 |
| 166 | Congenital sensorineural hearing impairment (HP:0008527) | 1.72167661 |
| 167 | Progressive inability to walk (HP:0002505) | 1.69662241 |
| 168 | Febrile seizures (HP:0002373) | 1.69338210 |
| 169 | Chorioretinal atrophy (HP:0000533) | 1.69125668 |
| 170 | Sclerocornea (HP:0000647) | 1.68837845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.48815018 |
| 2 | TTN | 3.85125647 |
| 3 | PDK3 | 3.50092756 |
| 4 | PDK4 | 3.50092756 |
| 5 | TRIB3 | 3.29048685 |
| 6 | ADRBK2 | 2.89415391 |
| 7 | TIE1 | 2.88928214 |
| 8 | SIK1 | 2.77298218 |
| 9 | OBSCN | 2.65990710 |
| 10 | PKN2 | 2.64607600 |
| 11 | PINK1 | 2.48658096 |
| 12 | GRK1 | 2.41181573 |
| 13 | PHKG2 | 2.37521241 |
| 14 | PHKG1 | 2.37521241 |
| 15 | FGFR4 | 2.34052840 |
| 16 | LMTK2 | 2.31084399 |
| 17 | INSRR | 2.28139832 |
| 18 | MYLK | 2.26055002 |
| 19 | PDK2 | 2.11839360 |
| 20 | ERN1 | 2.07291698 |
| 21 | WNK3 | 1.94639671 |
| 22 | BMPR1B | 1.93571829 |
| 23 | ACVR1B | 1.91341438 |
| 24 | OXSR1 | 1.84426417 |
| 25 | MAP4K2 | 1.78192329 |
| 26 | CASK | 1.70051319 |
| 27 | PIK3CA | 1.68225054 |
| 28 | MAPK13 | 1.65334379 |
| 29 | PRKAA2 | 1.53774279 |
| 30 | CAMK1D | 1.53144373 |
| 31 | WNK4 | 1.47579046 |
| 32 | TNK2 | 1.41959336 |
| 33 | NUAK1 | 1.39774752 |
| 34 | TXK | 1.36439119 |
| 35 | FLT3 | 1.28893639 |
| 36 | ADRBK1 | 1.27084540 |
| 37 | NEK9 | 1.23707373 |
| 38 | NEK1 | 1.21637404 |
| 39 | CDK19 | 1.19943976 |
| 40 | LATS1 | 1.13678672 |
| 41 | PRKAA1 | 1.13033367 |
| 42 | MAPK11 | 1.12799312 |
| 43 | STK38L | 1.11274519 |
| 44 | ERBB4 | 1.11168853 |
| 45 | KDR | 1.11100729 |
| 46 | MAPK12 | 1.10761586 |
| 47 | MAPK15 | 1.08920335 |
| 48 | MARK1 | 1.08262377 |
| 49 | MUSK | 1.08173202 |
| 50 | MAP3K7 | 1.06575144 |
| 51 | TLK1 | 1.06027292 |
| 52 | MAP2K4 | 1.05504294 |
| 53 | DMPK | 1.04972579 |
| 54 | PTK2B | 1.02578366 |
| 55 | TNIK | 0.98579823 |
| 56 | CAMK1 | 0.92356330 |
| 57 | NTRK3 | 0.92024712 |
| 58 | PIK3CG | 0.91808620 |
| 59 | PRKD1 | 0.89756418 |
| 60 | PRKCE | 0.89638347 |
| 61 | MAP2K3 | 0.89161014 |
| 62 | PAK3 | 0.87975739 |
| 63 | NLK | 0.87806817 |
| 64 | MAP3K4 | 0.85468312 |
| 65 | GRK7 | 0.85378226 |
| 66 | CAMK1G | 0.85183488 |
| 67 | STK11 | 0.82927190 |
| 68 | IRAK1 | 0.81677036 |
| 69 | MST1R | 0.81166928 |
| 70 | PTK6 | 0.78407777 |
| 71 | CAMKK2 | 0.77988496 |
| 72 | PKN1 | 0.77476865 |
| 73 | STK39 | 0.77197064 |
| 74 | PRKACG | 0.76836372 |
| 75 | RIPK1 | 0.75388162 |
| 76 | CAMK4 | 0.75208277 |
| 77 | TRPM7 | 0.74797594 |
| 78 | PDPK1 | 0.74171287 |
| 79 | ABL2 | 0.74052546 |
| 80 | TGFBR2 | 0.73096834 |
| 81 | JAK1 | 0.73007930 |
| 82 | MAP3K5 | 0.71631943 |
| 83 | MAP3K3 | 0.71098860 |
| 84 | SGK3 | 0.70749336 |
| 85 | TYK2 | 0.69181321 |
| 86 | CAMK2D | 0.68425249 |
| 87 | FGFR2 | 0.66400927 |
| 88 | PRKCG | 0.66164180 |
| 89 | PRKG1 | 0.65838347 |
| 90 | TEC | 0.65620465 |
| 91 | DYRK2 | 0.65481652 |
| 92 | NME1 | 0.65448566 |
| 93 | JAK2 | 0.65345338 |
| 94 | TAOK3 | 0.64082485 |
| 95 | IKBKB | 0.62068011 |
| 96 | KIT | 0.61937742 |
| 97 | ERBB3 | 0.60296701 |
| 98 | CAMK2G | 0.60253333 |
| 99 | STK24 | 0.60222419 |
| 100 | MARK3 | 0.60020741 |
| 101 | EPHB1 | 0.59635358 |
| 102 | PDGFRA | 0.57534570 |
| 103 | FER | 0.56919287 |
| 104 | PRKCQ | 0.55418683 |
| 105 | MAPK4 | 0.54162176 |
| 106 | PNCK | 0.53587233 |
| 107 | TGFBR1 | 0.53261800 |
| 108 | SGK2 | 0.52847293 |
| 109 | PDK1 | 0.49033289 |
| 110 | FRK | 0.47570135 |
| 111 | FGFR3 | 0.47017332 |
| 112 | TBK1 | 0.46226441 |
| 113 | STK4 | 0.45900946 |
| 114 | ROCK1 | 0.44689024 |
| 115 | DAPK2 | 0.44418926 |
| 116 | CHUK | 0.43869578 |
| 117 | IRAK4 | 0.43340574 |
| 118 | EPHA3 | 0.42706577 |
| 119 | GSK3A | 0.41956317 |
| 120 | NME2 | 0.40176800 |
| 121 | STK38 | 0.39597207 |
| 122 | PRKACB | 0.39511633 |
| 123 | MAP2K1 | 0.39160850 |
| 124 | ITK | 0.39127898 |
| 125 | LATS2 | 0.38659584 |
| 126 | PRKACA | 0.37938792 |
| 127 | MAPK7 | 0.37801570 |
| 128 | IRAK3 | 0.37600588 |
| 129 | MTOR | 0.37027871 |
| 130 | ICK | 0.36414795 |
| 131 | PRKCH | 0.36262909 |
| 132 | MAPKAPK3 | 0.34773932 |
| 133 | IKBKE | 0.33743698 |
| 134 | CAMK2A | 0.33707295 |
| 135 | AKT2 | 0.32885429 |
| 136 | MAP3K11 | 0.32376906 |
| 137 | PRKCZ | 0.32368426 |
| 138 | PRKCA | 0.32321655 |
| 139 | SYK | 0.31483174 |
| 140 | MAP2K6 | 0.31206607 |
| 141 | SIK2 | 0.30894027 |
| 142 | ZAK | 0.30810681 |
| 143 | SGK223 | 0.30397672 |
| 144 | SGK494 | 0.30397672 |
| 145 | IGF1R | 0.30270337 |
| 146 | DAPK3 | 0.29970889 |
| 147 | MAP2K7 | 0.29295607 |
| 148 | RPS6KA5 | 0.29138075 |
| 149 | RPS6KL1 | 0.28453847 |
| 150 | RPS6KC1 | 0.28453847 |
| 151 | CDK4 | 0.28396440 |
| 152 | CSNK1A1 | 0.28295335 |
| 153 | MKNK2 | 0.27690139 |
| 154 | GRK5 | 0.27609378 |
| 155 | SGK1 | 0.27312694 |
| 156 | TRIM28 | 0.27097507 |
| 157 | RPS6KA6 | 0.25836829 |
| 158 | MAP3K6 | 0.25591310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.51834327 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.50978829 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.41672073 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.36885623 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.23074503 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.11292813 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.99398911 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.85606359 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.74476599 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.59543989 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59281911 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50581216 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40652014 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.40313455 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37257700 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.27810207 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.07495135 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 2.00171956 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.97185979 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94680709 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.94388991 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.91922775 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84427615 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77551099 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57188701 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.55312132 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49335116 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.48048667 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41415929 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39515920 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.38093690 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33200800 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31689476 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30539910 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30269630 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27272204 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25438235 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25242439 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.23873776 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.21161946 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.18000032 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17478471 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14045502 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13747914 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.12391893 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12280027 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10488727 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08987444 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05785735 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04885718 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.03085335 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00217171 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97278019 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.96823809 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92595526 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90376622 |
| 57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89824809 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89129131 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.89002477 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88041651 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.86672609 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82038544 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79710287 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77465600 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74046760 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70086418 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69159771 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69122586 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68058170 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67710325 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67491751 |
| 72 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64345129 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60808260 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59864415 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.59521395 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59396023 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59302983 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59188008 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.58141249 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55667082 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.54335518 |
| 82 | Taste transduction_Homo sapiens_hsa04742 | 0.53872145 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53137747 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52630751 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50731758 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48171981 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47259476 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46697621 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45700417 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45082802 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42629442 |
| 92 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42458834 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41476434 |
| 94 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41378511 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40225828 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.39851129 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38302281 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38220596 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37798615 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37718401 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35681120 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.35164626 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.33462459 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.31519064 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27663466 |
| 106 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.25598030 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21834625 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18864845 |
| 109 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.16670125 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.16106522 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.13064520 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10757257 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10197625 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.08102838 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06234428 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01746986 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.01101534 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.1604179 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1516079 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1515021 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.1066327 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0830376 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0531267 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0345348 |

